Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin ED90 for Postpartum Uterine Atony
NCT00785395Phase 4Completed
- Sponsor
- IWK Health
- Start
- Jun 2008
- Primary completion
- Aug 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of oxytocin in uterine atony and postpartum hemorrhage (PPH), sponsored by IWK Health. Primary endpoint: Response of effective uterine contraction at 3 minutes. Started Jun 2008; status: completed.
02
Drugs
oxytocin
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT00785395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785395.